Gde Sastra Winata

Gde Sastra Winata

Auto-generated profile, based on publicly available information

Gde Sastra Winata

Master of health law study program, Udayana University, Bali, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2022 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
WSWinata I. Gde Sastra
Winata I. Gde Sastra
PAPrayudi Pande Kadek Aditya
Prayudi Pande Kadek Aditya
OGOngko Eric Gradiyanto
Ongko Eric Gradiyanto
SKSuwiyoga Ketut
Suwiyoga Ketut
BACKGROUND: It is essential in the management of ovarian cancers to identify the patients who will benefit from primary complete cytoreductive surgery and those who will rather benefit from neoadjuvant chemotherapy. OBJECTIVE: To evaluate the predictive value of preoperative inflammatory markers, i.e. platelet to lymphocyte ratio (PLR), neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), red cell distribution width (RDW), and serum CA125 level for surgical outcome in epithelial ovarian cancer. METHODS: A retrospective study was carried out in Sanglah Hospital, Denpasar, Bali. A total of 54 patients with epithelial ovarian cancer who underwent primary exploratory laparotomy from January 2018 to November 2019 was recruited. Data about clinical characteristics, preoperative inflammatory markers, serum CA125 level, and surgical outcome (optimal vs. suboptimal) was collected from the medical records. Predictive value of the markers were evaluated using ROC curve to determine their accuracy (area under the curve, sensitivity, specificity, positive and negative predictive value). RESULTS: Mean age, parity, and tumor size did not differ between the study groups (p> 0.05). The group with suboptimal outcome had significantly higher PLR, NLR, MLR, and RDW value (p< 0.05). Using the ROC curve, a cut off value was determined for each predictor, i.e. PLR: 196.50, NLR: 3.34, MLR: 0.24, RDW: 13.19, CA125: 300.85. AUC for each predictor were as follows: PLR 0.718 (95% CI: 0.578–0.859), NLR 0.676 (95% CI: 0.529–0.823), MLR 0.700 (95% CI: 0.560–0.839), RDW 0.712 (95% CI: 0.572–0.852), CA125 0.593 (95% CI: 0.436–0.750). Sensitivity, specificity, and accuracy for predicting suboptimal outcome were as follows: PLR (74.2%, 69.6%, 72.2%), NLR (64.5%, 60.9%, 62.9%), MLR (74.2%, 59.1%, 66.7%), RDW (74.2%, 60.9%, 68.5%), CA125 (54.8%, 60.9%, 57.4%). We have some limitations such as small numbers of sample, we generalized whole kinds of ovarian cancer, and this study does not describe follow-up features. CONCLUSION: Preoperative serum inflammatory markers (PLR, MLR, and RDW) may serve as useful markers to predict the surgical outcome with fair accuracy in patients with epithelial ovarian cancer.

1 January 2025 in Infection & Chemotherapy
Verified
Journal Article
Open access
IWI Gde Sastra Winata
I Gde Sastra Winata
LLLeonardo Leonardo
Leonardo Leonardo
RSRosalia Sylfiasari
Rosalia Sylfiasari
AEAngeline Ekafentie
Angeline Ekafentie
SISurya Sinaga Immanuel
Surya Sinaga Immanuel
FCFenyta Christyani
Fenyta Christyani
Winata IG, et al. Infect Chemother. 2025 Mar;57:e16. https://doi.org/10.3947/ic.2024.0120

30 June 2022 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
IWI Gde Sastra Winata
I Gde Sastra Winata
IBI Nyoman Gede Budiana
I Nyoman Gede Budiana
IJI Made Jawi
I Made Jawi
KSKetut Suwiyoga
Ketut Suwiyoga
This study aimed to describe Paclitaxel-Carboplatin chemotherapy as neoadjuvant chemotherapy in stage IB3, IIA2 and IIB cervical cancer. The review was conducted by collecting journals from previous studies discussing neoadjuvant chemotherapy in cervical cancer stages IB3, IIA2, and IIB and in this case specifically discussing Paclitaxel-Carboplatin chemotherapy. Neoadjuvant chemotherapy refers to systemic therapy intended to reduce the size of the tumour before the definitive operation. Several studies have shown that neoadjuvant chemotherapy has greater advantages than surgery alone for early stage cancers (IB3, IIA2, and IIB). Paclitaxel and Carboplatin are known chemotherapeutic agents that can be used as neoadjuvant chemotherapy. Neoadjuvant Chemotherapy regimen Paclitaxel Carboplatin is one of the options in performing therapy for early stage cervical cancer which can be very helpful in healing and cancer-free patient condition. Neoadjuvant chemotherapy followed by radical surgery has significant benefits that have been described in several previous studies. Neoadjuvant Chemotherapy regimen Paclitaxel Carboplatin may be used as therapy regimen for early stage cervical cancer with all advantage compared to only surgery. Thus, this type of regimen can be used to decrease mortality and morbidity in patient with stadium IB3, IIA2 and IIB cervical cancer.

26 December 2023 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
PPPande Kadek Aditya Prayudi
Pande Kadek Aditya Prayudi
IWI Gde Sastra Winata
I Gde Sastra Winata
IMI Nyoman Bayu Mahendra
I Nyoman Bayu Mahendra
IBI Nyoman Gede Budiana
I Nyoman Gede Budiana
KSKade Yudi Saspriyana
Kade Yudi Saspriyana
KSKetut Suwiyoga
Ketut Suwiyoga
Objective: To understand the basic mechanism and dynamic regulation that underlies the epithelial-to-mesenchymal transition (EMT) in ovarian cancer (OC) cells. Mechanism: A literature review using evidences from several data bases (i.e., PubMed, EMBASE, Web of Science, Medline, Cochrane, Science Direct, and Google Scholar) were conducted to describe the basic mechanism and dynamic regulation of EMT in OC cells. Finding in Brief: EMT is a complex epigenetic reprogramming orchestrated by specific transcription factors (TFs) and multiple upstream activators and regulators, such as transforming growth factor-β (TGF-β), Wnt, Hedgehog, and Hippo signaling pathways. The net result of this cellular reprogramming is the acquisition of mesenchymal phenotypes with increased invasive and metastatic potential, stemness properties and chemoresistance. Recent studies have demonstrated that EMT activation is the result of dynamic and reciprocal interplay between OC cells and their tumor microenvironment (TME). Cellular or non-cellular component of TME, external factors related to TME such as hypoxia, oxidative stress, mechanical forces, as well as exposure to chemotherapy, all play significant role to EMT induction. Current understanding behind the mechanism of EMT induction in cancer cells have proposed the idea that EMT is not merely a binary process involving a complete conversion from epithelial to mesenchymal state, but rather a dynamic process that encompasses a range of hybrid states, a phenotype that has been referred to as “partial EMT”. Cells with partial EMT have been known to be more apoptosis-resistant and have more tumor-initiating potential as compared to those with complete EMT. Conclusions: Understanding the complex regulatory network that underlies EMT in OC cells is crucial in order to gain insight in developing novel and effective treatment strategies for OC.

2 February 2023 in Indonesian Journal of Perinatology
Verified
Journal Article
Open access
PDF file
IWI Gde Sastra Winata
I Gde Sastra Winata
WSWilliam Alexander Setiawan
William Alexander Setiawan
NWNi Luh Wita Astari Widhusadi
Ni Luh Wita Astari Widhusadi
DMDpg Jananuraga Maharddhika
Dpg Jananuraga Maharddhika
FCFenyta Christyani
Fenyta Christyani
ESErnest Tb Sianturi
Ernest Tb Sianturi
Treponema pallidum, which causes the infectious disease syphilis, has a high rate of vertical transfer from mother to kid. Untreated maternal infection increases the risk of perinatal morbidity and mortality and unfavorable pregnancy outcomes, notably congenital syphilis. It is necessary to check for gestational syphilis during the prenatal period, and its diagnosis is straightforward. Nevertheless, this illness still affects two million pregnant women globally, indicating its significant prevalence. Congenital syphilis clinical symptoms are regulated by gestational age, maternal syphilis stage, maternal therapy, and fetus immune response. Early and late congenital syphilis have historically been used to describe it. The direct identification of treponemes, serological tests, and clinical signs all contribute to the diagnosis of maternal infection. Penicillin is typically used in the treatment, which also includes sexual partners. Fetal infection can be treated and prevented from spreading from the mother to the fetus with proper maternal infection management. To lower the prevalence of congenital syphilis, screening, early detection, and appropriate care are crucial during pregnancy and the preconception period.

16 September 2023 in Journal of South Asian Federation of Obstetrics and Gynaecology
Verified
Journal Article
Open access
IMI Wayan Megadhana
I Wayan Megadhana
IWI Gde Sastra Winata
I Gde Sastra Winata
EWEndang Sri Widiyanti
Endang Sri Widiyanti
ALAldo Albert Lawu
Aldo Albert Lawu